ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| 1 |
Teladoc Health
TDOC
|
$1.2B |
| 2 |
Tesla
TSLA
|
$1.1B |
| 3 |
XYZ
Block, Inc.
XYZ
|
$885M |
| 4 |
Zoom
ZM
|
$658M |
| 5 |
Shopify
SHOP
|
$656M |
Top Sells
| 1 |
TSMC
TSM
|
$486M |
| 2 |
SPLK
Splunk Inc
SPLK
|
$272M |
| 3 |
CRISPR Therapeutics
CRSP
|
$259M |
| 4 |
Pacific Biosciences
PACB
|
$240M |
| 5 |
Pinterest
PINS
|
$225M |
Sector Composition
| 1 | Healthcare | 30.99% |
| 2 | Technology | 24.52% |
| 3 | Communication Services | 14.26% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Financials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fate Therapeutics
FATE
$115M
| $540M | 1.07% |
6,554,546
+3,652,846
| +126% | +$301M |
|
|
TWTR
27
DELISTED
Twitter, Inc.
TWTR
| $496M | 0.99% |
+7,793,240
| New | +$496M |
|
|
TWOU
28
DELISTED
2U, Inc.
TWOU
| $453M | 0.9% |
394,569
-47,484
| -11% | -$54.5M |
|
29
Protolabs
PRLB
$1.17B
| $445M | 0.88% |
3,654,854
-465,068
| -11% | -$56.6M |
|
30
Grayscale Bitcoin Trust
GBTC
$45B
| $434M | 0.86% |
9,604,200
+1,515,099
| +19% | +$68.5M |
|
31
Palantir
PLTR
$367B
| $434M | 0.86% |
18,632,471
+17,315,349
| +1,315% | +$403M |
|
32
Iridium Communications
IRDM
$2.62B
| $427M | 0.85% |
10,355,147
+3,384,917
| +49% | +$140M |
|
33
Veracyte
VCYT
$2.41B
| $409M | 0.81% |
7,617,287
-1,410,540
| -16% | -$75.8M |
|
34
PayPal
PYPL
$66.5B
| $408M | 0.81% |
1,679,629
-905,060
| -35% | -$220M |
|
35
PagerDuty
PD
$1.44B
| $402M | 0.8% |
9,982,602
-1,565,231
| -14% | -$63M |
|
36
JD.com
JD
$44.2B
| $392M | 0.78% |
4,651,745
+3,013,962
| +184% | +$254M |
|
37
Beam Therapeutics
BEAM
$1.9B
| $383M | 0.76% |
4,779,104
+3,647,481
| +322% | +$292M |
|
38
Synopsys
SNPS
$110B
| $381M | 0.76% |
1,537,753
+516,571
| +51% | +$128M |
|
39
Vertex Pharmaceuticals
VRTX
$102B
| $369M | 0.73% |
1,719,046
+902,852
| +111% | +$194M |
|
40
Editas Medicine
EDIT
$225M
| $368M | 0.73% |
8,751,923
-1,373,641
| -14% | -$57.7M |
|
41
LendingTree
TREE
$933M
| $367M | 0.73% |
1,723,091
-287,164
| -14% | -$61.2M |
|
42
Teradyne
TER
$19B
| $350M | 0.7% |
2,877,103
+2,639,056
| +1,109% | +$321M |
|
43
Takeda Pharmaceutical
TAK
$47.8B
| $342M | 0.68% |
18,717,144
+10,098,979
| +117% | +$184M |
|
44
CareDx
CDNA
$678M
| $304M | 0.6% |
4,460,824
+398,502
| +10% | +$27.1M |
|
45
PACCAR
PCAR
$50.5B
| $293M | 0.58% |
+4,736,478
| New | +$293M |
|
|
SI
46
DELISTED
Silvergate Capital Corporation
SI
| $276M | 0.55% |
1,939,369
+1,308,580
| +207% | +$186M |
|
47
Stratasys
SSYS
$863M
| $270M | 0.54% |
10,420,260
-1,667,401
| -14% | -$43.2M |
|
48
DraftKings
DKNG
$23.7B
| $268M | 0.53% |
+4,375,424
| New | +$268M |
|
|
MTLS
49
Materialise
MTLS
$291M
| $268M | 0.53% |
7,441,821
-1,122,260
| -13% | -$40.3M |
|
|
CELL
50
DELISTED
PhenomeX Inc. Common Stock
CELL
| $257M | 0.51% |
5,115,992
+3,651,475
| +249% | +$183M |
|